Canton Strategic Holdings (CNTN) Retained Earnings (2020 - 2026)
Canton Strategic Holdings' (CNTN) quarterly Retained Earnings came in at $590.0 million in Q1 2026, up 1597.52% YoY from $34.8 million in Q1 2025, and up 910.28% on a QoQ basis from -$72.8 million in Q4 2025.
Analysis
Canton Strategic Holdings (CNTN) Retained Earnings (2020 - 2026) Analysis & Trends
Canton Strategic Holdings (CNTN) has 7 years of Retained Earnings data on file, last reported at $590.0 million in Q1 2026.
- Quarterly Retained Earnings rose 1597.52% year-over-year to $590.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $590.0 million (up 1597.52% YoY) and the FY2025 annual result came in at -$72.8 million, down 290.23% from the prior year.
- Retained Earnings rose to $590.0 million in Q1 2026, from -$72.8 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $590.0 million in Q1 2026 to a low of -$72.8 million in Q4 2025.
- A 5-year average of $32.1 million and a median of -$9.9 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings tumbled 791.21% — and 2026, when it jumped 1597.52%.
- Tracing CNTN's Retained Earnings over 5 years: stood at -$15.4 million in 2022, then slumped by 60.57% to -$24.7 million in 2023, then jumped by 254.95% to $38.3 million in 2024, then slumped by 290.23% to -$72.8 million in 2025, then surged by 910.28% to $590.0 million in 2026.
- The last three Retained Earnings figures came in at $590.0 million (Q1 2026), -$72.8 million (Q4 2025), and -$43.4 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 5.10 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -4.00 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 13.05 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -6.33 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 4.38 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Canton Strategic Holdings | 493.37 Mn | 493.37 Mn | - | 594.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 594.38 Mn |
| Mar 31, 2026 | 590.02 Mn |
| Dec 31, 2025 | 470.81 Mn |
| Sep 30, 2025 | 49.62 Mn |
| Jun 30, 2025 | 41.73 Mn |
| Mar 31, 2025 | -39.44 Mn |
| Dec 31, 2024 | 38.28 Mn |
| Sep 30, 2024 | 36.17 Mn |
| Jun 30, 2024 | 36.05 Mn |
| Mar 31, 2024 | 34.08 Mn |
| Dec 31, 2023 | 33.90 Mn |
| Sep 30, 2023 | 24.05 Mn |
| Jun 30, 2023 | 23.55 Mn |
| Mar 31, 2023 | 21.34 Mn |
| Dec 31, 2022 | 21.00 Mn |
| Sep 30, 2022 | 20.79 Mn |
| Jun 30, 2022 | 20.55 Mn |
| Mar 31, 2022 | 20.19 Mn |
| Dec 31, 2021 | -6.91 Mn |
| Dec 31, 2020 | -4.70 Mn |